Seminal vesicle biopsy: Accuracy and implications for staging of prostate cancer

Urology

Volumn 48, Issue 5, 1996, Pages 757-761

  Linzer, Debra G ^a   Stock, Richard G ^a,b   Stone, Nelson N ^a   Ratnow, Rebecca ^a   Ianuzzi, Christopher ^a   Unger, Pamela ^a  

^a MOUNT SINAI HOSPITAL   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; SEMINAL VESICLE DISEASE;

ADENOCARCINOMA; BIOPSY, NEEDLE; GENITAL NEOPLASMS, MALE; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SEMINAL VESICLES;

EID: 0030298331     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00422-0     Document Type: Article

References (21)

1. 1. Parker SL, Tong T, Bolden S, et al: Cancer statistics. CA Cancer J Clin 46: 1, 1996.
2. 2. DeAntoni E, Crawford ED, Stone NN, et al: Prostate Cancer Awareness Week, 1992. A summary of key findings. Clin Invest Med 16: 448-457, 1992.
3. 3. Partin AW, Yoo J, Carter HB, et al: The use of prostate-specific antigen, clinical stage and Gleason score to predict pathologic stage in men with localized prostate cancer. J Urol 150: 110-114, 1993.
4. 4. Smith JA, Hernandez AD, Wittwer CJ, et al: Long term follow-up after radical prostatectomy. Identification of prognostic variables. Urol Clin North Am 18: 473-476, 1991.
5. 5. Walsh PC, Partin AW, and Epstein JI: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152: 1831-1836, 1994.
6. 6. Zeitman AL, Edelstein RA, Coen JJ, et al: Radical prostatectomy for adenocarcinoma of the prostate. The influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology 43: 828-833, 1994.
7. 7. Zincke H, Oesterling JE, Blute ML, et al: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 152: 1850-1857, 1994.
8. 8. Allepuz Losa CA, Sanz Velez JI, Gilsanz MJ, et al: Seminal vesicle biopsy in prostate cancer staging. J Urol 154: 1407-1411, 1995.
9. 9. Terris MK, McNeal JE, Freiha FS, et al: Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J Urol 149: 1035-1039, 1993.
10. 10. Mukamel E, DeKernion JB, Hanna H, et al: The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer 59: 1535-1538, 1987.
11. 11. Catalona WJ, and Smith DS: 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152: 1837-1842, 1994.
12. 12. Trapasso JG, DeKernion JB, Smith RB, et al: The incidence and significance of detectable levels of serum prostate-specific antigen after radical prostatectomy. J Urol 152: 1821-1825, 1994.
13. 13. Stock RG, Stone NN, Ianuzzi C, et al: Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection. Implications for patient selection in the radiotherapeutic management of prostate cancer. Int J Radiat Oncol Biol Phys 33: 815-821, 1995.
14. 14. Stone NN, Stock RG, and Unger P: Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol 154: 1393-1396, 1995.
15. 15. Feinberg SE: The Analysis of Cross-Classified Data, 2nd ed. Cambridge, Mass, MIT Press, 1986.
16. 16. Oesterling JE, Brendler CB, Epstein JI, et al: Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138: 92-98, 1987.
17. 17. D'Amico AV, Whittington R, Malkowicz SB, et al: A multivariate analysis of clinical and pathological factors that predict for prostate-specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154: 131-138, 1995.
18. 18. Anscher MS, and Prosnitz LR: Multivariate analysis of factors predicting local relapse after radical prostatectomy - possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys 21: 941-947, 1991.
19. 19. Cheng WS, Frydenberg N, Bergstralh EJ, et al: Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Adult Urol 42: 283-291, 1993.
20. 20. Vallencien G, Bochereau G, Wetzel O, et al: Influence of preoperative positive seminal vesicle biopsy on the staging of prostatic carcinoma. J Urol 152: 1152-1156, 1994.
21. 21. Pandey P, Fowler JE Jr, Seaver LE, et al: Ultrasound guided seminal vesicle biopsies in men with suspected prostate cancer. J Urol 154: 1798-1801, 1995.